A recent study demonstrated that loss of heterozygosity at the ATP7B locus was associated with an improved response to Pt-based chemotherapy in 17 patients with metastatic BC, suggesting that impaired efflux promoted cytotoxicity [28]. This evidence concerns the gene ATP7B and breast cancer.